Skip to main content

Home/ PHE - Resources/ Group items tagged informed-consent

Rss Feed Group items tagged

Dennis OConnor

Approaches to governance of participant-led research: a qualitative case study | BMJ Open - 0 views

  •  
    "Prospective consent and governance principles for participant-led research Nine themes emerged from discussions and interviews relating to informed consent in and governance of PLR. As this PLR was driven by people with different backgrounds asking personal questions, we found that ethical reflection needed to be ongoing and tailored to the individual. For this reason, prospective governance principles were drafted rather than codified rules. Many of the themes were expressed over the course of our PLR as an ongoing informed consent. The process, fostered via frequent communication, helped to reinforce trust among participants and organisers.43 44 Transparency: All relevant information about the project should be actively shared among participants and participant-organisers, including the source of research funding, equipment selection, data management protocols, risks and benefits and conflicts of interest. Access to Expertise: Participant-led research (PLR) requires access to experts (eg, in experimental design, data analysis, research ethics) so that participants can rigorously carry out single-subject experiments.45 Data Access & Control: The participant has the right and ability to manage their own data, and has the final say in what they collect about themselves. Right to Withdraw: Participants have a right to reduce or withdraw their participation at any time. Relevance: PLR addresses questions of relevance to the participants. Beneficence: The participant actively reflects on the balance of benefits and risks of participation and freely choose whether to participate. Responsibility: PLR requires that the participant actively consider the potential benefits and harms of the project to both themselves and others. The responsibility to stay informed is an ongoing process, not a one-time decision. Flexibility: Ethical reflection in PLR should be tailored to individual needs and to the specific context, rather than be handled with 'one size fits allâ€
Dennis OConnor

N1: wellness by experiment - Down App to experiment - 0 views

  •  
    N1: wellness by experiment 17+ Back your wellness with data INGH Available on iOS only You can use this app to join a clinical trial on cognition. Comparing 2 treatments using caffeine (50-400 mg) and caffeine (50-400 mg) in combination with L-theanine (250 mg) : L-theanine is a naturally occurring amino acid most commonly found in green tea. I've downloaded the app will join the study. Interesting screen by screen informed consent process. Will report what I discover at an upcoming Apollo Meeting.
Dennis OConnor

[CSA Webinar] Approaching Informed Consent in Citizen Science: Legal and Ethical Issues - 1 views

  •  
    "  Presented by the Law and Policy Working Group and Ethics Working Group Date: Friday, November 22, 2019, from 1:00 PM to 2:15 PM EST Presented by the Law and Policy Working Group and Ethics Working Group Date: Friday, November 22, 2019, from 1:00 PM to 2:15 PM EST"
Dennis OConnor

I Tried to Get My DNA Back From 23andMe. Here's What Happened. - 0 views

  • I did want to find out what exactly happens to someone’s DNA when they send it to one of these companies, and more importantly, if getting a sample back from them is possible.
  • DNA testing isn’t an exact science
  • I wanted to understand what was happening with my actual genetic information.
  • ...11 more annotations...
  • I had chosen to “biobank” my sample in case I desired further testing,
  • my DNA has been sold to them if I consented to take part in their research
  • Winston says that when it comes to arbitration, 23andMe goes a bit further than other companies in that there’s a “fee-shifting provision,”
  • basically all of these companies work with pharmaceutical companies in one way or another
  • one of the concerns about 23andMe, as well as other DNA testing services like Ancestry and My Heritage, is that they’re not the ones directly processing your sample.
  • they’re creating a mass database of information that they can now monetize by selling it to pharmaceutical companies
  • “Clearly, their goal is to acquire this information for medical and pharmaceutical purposes.”
  • While they do send aggregated data, there have been cases where individual data has proven to be useful to big companies.
  • if they receive an actual warrant, he doesn’t see how they could refuse
  • While life insurance companies can’t get that data yet, Winston says that they can ask if you’ve taken any such test, which might tell them if you’re predisposed to breast cancer or something like that.
  • their terms of service, also known as their verbal chloroform.
  •  
    "I want it like I never dealt with 23andMe, which, as it turns out, is pretty much impossible - at least for the next decade."
Dennis OConnor

How a decades-old database became a hugely profitable dossier on the health of 270 mill... - 0 views

  •  
    "As a repository of sensitive patient information, the company's databases churn silently behind the scenes of their medical care, scooping up their most guarded secrets: the diseases they have, the drugs they're taking, the places their bodies are broken that they haven't told anyone but their doctor. The family of databases that make up MarketScan now include the records of a stunning 270 million Americans, or 82% of the population. The vast reach of MarketScan, and its immense value, is unmistakable. Last month, a private equity firm announced that it would pay $1 billion to buy the databases from IBM. It was by far the most valuable asset left for IBM as the technology behemoth cast off its foundering Watson Health business."
1 - 5 of 5
Showing 20 items per page